Become the Go-to Solution Expert Across APAC’s Growing Cell & Gene Therapy Market
파트너십
South Korea’s cell and gene therapy demand in raw materials, manufacturing and facility expansion is scaling rapidly, driven by major CDMO investments, specialized GMP infrastructure, and a supportive dual-track regulatory system. The market is actively shifting from a primary focus on stem cell research to complex modalities like CAR-T, plasmids, and viral vectors.
Partnering with the inaugural World Cell & Gene Therapy Summit South Korea is the perfect opportunity for those companies seeking to enter the South Korean market to find new clients or partners. The audience will span 80+ attendees expected from APAC and the West, including CxOs, Directors, Heads, and Scientists focused on scaling CGT from research to GMP level.
Supporting advancements in oncology, autoimmune diseases and more, position your company at the forefront and become the go-to partner for Korean CGT as organizations prepare for global trials and commercialization.
What to Expect?
Meet New Clients
Expand your client base within the CGT community by networking face-to-face with large pharma and new biotechs actively seeking solutions to overcome their drug development challenges.
Centre Yourself in Biopharma Dealmaking
Position your brand in front of C-Level decision-makers by showcasing your company logo on event materials including our website, brochure, and on-site signage.
Demonstrate Your Expertise
Present your work within one of our focused tracks, participate in a panel discussion or showcase your solutions in a bespoke exhibition booth to demonstrate your company's unique capabilities.
Gain Market Intelligence
Stay ahead of industry trends by hearing directly from KOLs. Gain insights and competitor strategies to shape your organization’s future and sharpen its competitive edge.
Key Services & Solutions
Our attendees from across biotech and pharma in the cell and gene therapy field are looking for service and solution providers with capabilities in the below areas but not limited to:
1
Optimizing Pre-Clinical Animal Models
2
Accelerating CGT Manufacturing from R&D to GMP Scale
3
Improving Analytical Tools for Release & Potency
4
Developing Clinical Trial Strategies & Patient Recruitment
5
Innovating Viral Vector & Non-Viral Delivery Technologies
6
Harnessing Cost-Effective Raw Material Supply & Distribution Channels
Audience Composition
Company Type
Attendee Seniority
Attendees by Location
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Kieran Crewe
Partnerships Director